A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
about
The genetic landscape of Alzheimer disease: clinical implications and perspectivesThe Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriersThe genetics and neuropathology of Alzheimer's diseaseUshering in the study and treatment of preclinical Alzheimer diseaseThe genetics of Alzheimer diseaseApolipoprotein E and Alzheimer disease: risk, mechanisms and therapyInteractive effects of physical activity and APOE-ε4 on BOLD semantic memory activation in healthy eldersGenetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkersStructural Neuroimaging Genetics Interactions in Alzheimer's DiseaseCharacterization of the poly-T variant in the TOMM40 gene in diverse populationsOverrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohortGenetics of vascular dementia - review from the ICVD working group.Meta-analysis of the rs2075650 polymorphism and risk of Alzheimer disease.Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals.Epigenetic signature and enhancer activity of the human APOE gene.Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients.Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentGenetics of Psychosis in Alzheimer Disease.Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP dataAssociation analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.Genetic variation at a single locus and age of onset for Alzheimer's disease.The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.The Alzheimer's disease mitochondrial cascade hypothesisAPOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.Using genetics to enable studies on the prevention of Alzheimer's diseaseAssociation between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort.Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directionsCerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairmentSystemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention.Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructureProbable early-onset Alzheimer's disease in an apolipoprotein E2 homozygoteAn empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?Association study of candidate gene polymorphisms with amnestic mild cognitive impairment in a Chinese populationHumans have antibodies against a plant virus: evidence from tobacco mosaic virus.
P2860
Q26796582-EC16A8A0-862A-41C0-9058-36B1ACEC3358Q26849380-57C372F5-2448-4BD5-85B5-BBABEC5D3CB1Q26998097-6BD7C081-B7BA-4EE6-922E-D1C790B35089Q27014791-505840AB-5994-462E-B6B3-668DF3F5A46DQ27026166-59F93607-0D48-41FD-B8B9-4C214521BDF6Q28282855-78F1C350-9345-4C46-9FC7-F7BED13D9696Q28384123-8E4F3DEB-DD74-49AC-9AE0-873B9B909F69Q28542010-44ABD4BC-E4A9-4A81-9F3E-BC26DF8DACC9Q28601824-2F2409A6-278F-4209-9DD9-23EAB9D95818Q28732044-6F3B8E5F-5E7E-40AF-BEBB-7103DE3CC5E4Q29417035-1710E7D2-2409-4D65-B253-F27AAD4D63F5Q29417147-58704F2E-8E78-4EFF-9B1B-84A935E91606Q30235432-43C8CC95-EF40-4708-A8CE-FAB93D2BE199Q30252037-8F82682E-463B-41E7-AB4F-8A906E339260Q30414047-01CF4E19-C87E-47FC-929C-FFDBB0F398F7Q30557542-5D387666-8DF1-41D0-A29F-682408D56AFFQ30680866-91DFF231-FFA0-476C-9789-44C330DC7FA8Q33607473-413F63B4-BE5B-4F3F-96B7-D9D0AEDAA34BQ33629452-4870A636-F10D-48F6-B375-701C408B81D2Q33666458-575B9EAB-C8A9-45EE-BBF4-FB81772CD352Q33713286-3B444355-6D0D-4DF6-ABCE-1FA0115FC645Q33753746-BDD34D54-C974-45EF-81BF-77EF2D7FA0E6Q33770976-F3EDBA69-5F97-4438-BEAC-47B1E9CD4DF9Q33846034-AED5DDA5-8E32-4389-AEE8-B420D48C4A02Q33870512-E2280909-2395-4A62-9B70-DFD8583D1A1FQ33901364-37489BFC-846E-4674-9276-926716437F2AQ33905871-034EC8A5-60A6-4D17-AB72-AF394DA9F23EQ34034409-CE567551-20B4-44E3-B53C-4893627B39F4Q34038890-7E2D9453-A11D-4B0D-891E-2BF829512280Q34054660-AF5CF78D-AA1B-45B1-B6D0-2A44F4E71753Q34135724-5366582C-BE79-42AC-A329-58B98B88BE08Q34175825-7CB0028E-DBFC-44F0-8FEF-5E907EA4C84FQ34246990-4EE5EE14-9207-425B-B961-E914CE994957Q34303501-79C20FEF-F150-4AB6-8797-4C4573268DFFQ34344559-4D24656E-B5A9-45C8-A9A1-0725F487D23EQ34354478-0FC12A7C-2A7A-44EC-8FBE-5CF822214A0DQ34364368-3E5DB1AA-55E2-42C1-A897-CFD471AAC925Q34370525-49A1FE07-285F-4F68-BD4F-BCB455321C59Q34387717-44AFAFF6-9515-4D2A-B9D7-E6B5AEE79F53Q34662054-CE384AE4-6EB7-48B4-9E84-90881ADF1C7E
P2860
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
@ast
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
@en
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
@nl
type
label
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
@ast
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
@en
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
@nl
prefLabel
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
@ast
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
@en
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
@nl
P2093
P2860
P356
P1476
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
@en
P2093
A M Saunders
D G Crenshaw
E M Reiman
H Amrine-Madsen
K A Welsh-Bohmer
M J Huentelman
S S Sundseth
P2860
P2888
P304
P356
10.1038/TPJ.2009.69
P577
2009-12-22T00:00:00Z
P5875
P6179
1030319372